What is Ranolazine and what are its indications?
Ranolazine is an antianginal medication with minimal effects on heart rate and BP. It is currently indicated for the treatment of chronic angina. In a post hoc analysis in women, ranolazine was associated with a reduced incidence of the primary endpoint (cardiovascular death, MI, or recurrent ischemia), principally owing to a 29% reduction in recurrent ischemia.